Jane Street’s ABVC BioPharma ABVC Stock Holding History
Bought
Maintained
Sold
Other funds holding ABVC
Jane Street's ABVC Position: Q3 2026 in Review
Jane Street sold out of ABVC BioPharma (ABVC) in Q3 2026, closing a stake of 20,059 shares — an estimated $31.7K sold.
Jane Street first reported a position in ABVC in Q3 2022 and held it in 3 quarters. The position peaked at $31.7K in Q2 2026. 11 funds tracked by Wall St. Rank hold ABVC as of Q3 2026.
- Jane Street reported no remaining ABVC BioPharma position as of Q3 2026 after selling out during the quarter.
- Jane Street sold 20,059 ABVC BioPharma shares in Q3 2026, an estimated $31.7K.
- Jane Street first reported a position in ABVC BioPharma in Q3 2022 and held it in 3 quarters.
- Jane Street's ABVC BioPharma position peaked at $31.7K in Q2 2026.
- 11 funds tracked by Wall St. Rank held ABVC BioPharma as of Q3 2026.
Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.